03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
On Friday, May 1, 2020, the Trump administration issued an executive order prohibiting the acquisiti...
Read More >
Seyfarth Synopsis: The Cal/OSH Standards Board will vote this week on a proposed standard requiring...
Read More >
The Empire State Development Corporation (“ESDC”) issued guidance over the weekend clarifying the ...
Read More >
Popple Construction, Inc. v. Reilly Associates, Inc. No. 775-MDA-2017, 2019 BL 213236 (Pa. Sup. Ct.,...
Read More >
COVID-19 has put dealmaking in the already disrupted retail industry under further strain. Some reta...
Read More >
As cases of COVID-19 have started to spread throughout the United States, we have received a number ...
Read More >